6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Cannabis
Cannabis (popularly known as marijuana) is a hallucinogenic plant with over 500 components, 104 of which have been discovered so far. On the illicit drug market, there are numerous cannabis preparations available, including hashish, herbal cannabis (leaves and flowers), and oils.
Cannabis's therapeutic applications include: THC is the psychoactive component of cannabis which causes the drunkenness sought by many users. The American Academy of Neurology conducted a systematic assessment of publications on the use of cannabis in the management of multiple sclerosis, neurological diseases, and epilepsy from 1948 to November 2013. Only oral cannabis extracts (combined THC/CBD or CBD alone) shown efficacy in treating spasticity from lupus and central pain. Marijuana use and its harmful ramifications have grown in recent years.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States